Determination of nafazatrom in body fluids by high-performance thin-layer chromatography with post-chromatographic derivatization.
A sensitive, accurate and specific high-performance thin-layer chromatographic method has been developed for determination of nafazatrom, a pyrazolinone derivative with antithrombotic and antimetastatic activity. Because of the instability of the drug during clean-up procedures, nafazatrom is recovered from plasma and urine with a single extraction and the extract is spotted directly onto the chromatographic plate. The specificity of the assay was increased by post-chromatographic derivatization with 4-dimethylaminobenzaldehyde. Up to eight primary metabolites with an unchanged position 4 in the heterocyclic ring were also detected and separated chromatographically. The detection limit for nafazatrom is 0.5 ng per spot and 5 ng/ml. The analytical error in the nanogram per millilitre range is less than 10%, low enough for pharmacokinetic studies and for plasma level monitoring in patients.[1]References
- Determination of nafazatrom in body fluids by high-performance thin-layer chromatography with post-chromatographic derivatization. Ritter, W. J. Chromatogr. (1984) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
